Smith Group Asset Management’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-150,160
Closed -$16.2M 207
2024
Q3
$16.2M Buy
150,160
+2,941
+2% +$321K 1.34% 36
2024
Q2
$16M Buy
147,219
+4,893
+3% +$577K 1.42% 36
2024
Q1
$18.8M Buy
142,326
+18,510
+15% +$2.31M 1.08% 35
2023
Q4
$15.1M Buy
+123,816
New +$13.8M 0.88% 46

Other funds holding ZBH

Smith Group Asset Management's ZBH Position: Q4 2024 in Review

Smith Group Asset Management sold out of Zimmer Biomet (ZBH) in Q4 2024, closing a stake of 150,160 shares — an estimated $16.2M sold.

Smith Group Asset Management first reported a position in ZBH in Q4 2023 and held it in 4 quarters. The position peaked at $18.8M in Q1 2024. 1,027 funds tracked by Wall St. Rank hold ZBH as of Q4 2024.

  • Smith Group Asset Management reported no remaining Zimmer Biomet position as of Q4 2024 after selling out during the quarter.
  • Smith Group Asset Management sold 150,160 Zimmer Biomet shares in Q4 2024, an estimated $16.2M.
  • Smith Group Asset Management first reported a position in Zimmer Biomet in Q4 2023 and held it in 4 quarters.
  • Smith Group Asset Management's Zimmer Biomet position peaked at $18.8M in Q1 2024.
  • 1,027 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2024.

Based on Smith Group Asset Management's 13F filing for Q4 2024, filed 23 Jan 2025.